Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-20 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| 2024-12-23 | Amended | $1,215,000 | $555,000 | Debt Only | 06b | SEC link |
| 2024-07-31 | New | $660,000 | $660,000 | Debt Only | 06b | SEC link |
| 2023-12-27 | Amended | $1,744,999 | $994,999 | Equity Only | 06b | SEC link |
| 2022-12-21 | New | $750,000 | $750,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Brett Blackham | Director |
| Charles Breinholt | Director |
| Kristin Gonzales | Director |
| Davin Isakson | Executive |
| Sydnie Keddington | Director |
| Alan Nolley | Director, Executive, Promoter |
| Jeremy Stueven | Director, Executive, Promoter |
| Timothy Summers | Director, Executive, Promoter |
| Waneta Tuttle | Director |
| Jeffrey Wigdahl | Executive |
| Nathan Wyatt | Executive |